Lomecel-B medicinal signaling cells

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.NCT04925024LGVNPhase 2Active not recruiting2026-06-30Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.